$7.72
0.18 (+2.39%)
Incyte Corp (INCY)
CAPS Rating:
The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.
The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.